| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |